Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunbird Bio has developed first-in-class blood-based diagnostic tests capable of detecting key protein aggregates associated with major neurodegenerative diseases. Their technology enables non-invasive, highly accurate detection of multiple co-pathologies from a single blood draw. Clinical data presented to date reinforce the significance of their tau biomarker panel for Alzheimer's diagnosis. The company is expanding clinical studies to further validate its platform across additional neurological indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunbird Brewing.